The global market for Artemisinine was estimated to be worth US$ 62 million in 2023 and is forecast to a readjusted size of US$ 78 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030

Artemisinine - Market

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.

Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.

In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artemisinine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artemisinine by region & country, by Type, and by Application.

The Artemisinine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinine.

Market Segmentation

Scope of Artemisinine - Market Report

Report Metric	Details
Report Name	Artemisinine - Market
Forecasted market size in 2030	US$ 78 million
CAGR	3.3%
Forecasted years	2024 - 2030
Segment by Type:	Extraction from Artemisia annua Semisynthetic Artemisinine
Segment by Application	Injections Tablets Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, BEEPZ, KPC Pharmaceuticals, BIONEXX, Guangxi xiancaotang, Sanofi, Natural Bio-engineering, Kerui nanhai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artemisinine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Artemisinine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Artemisinine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Artemisinine - Market size in 2030?

Ans: The Artemisinine - Market size in 2030 will be US$ 78 million.

What is the market share of major companies in Artemisinine - Market?

Ans: Global top four manufacturers hold a share over 65%.

What is the Artemisinine - Market share by type?

Ans: In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%.

Who are the main players in the Artemisinine - Market report?

Ans: The main players in the Artemisinine - Market are Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, BEEPZ, KPC Pharmaceuticals, BIONEXX, Guangxi xiancaotang, Sanofi, Natural Bio-engineering, Kerui nanhai

What are the Application segmentation covered in the Artemisinine - Market report?

Ans: The Applications covered in the Artemisinine - Market report are Injections, Tablets, Others

What are the Type segmentation covered in the Artemisinine - Market report?

Ans: The Types covered in the Artemisinine - Market report are Extraction from Artemisia annua, Semisynthetic Artemisinine

1 Market Overview

1.1 Artemisinine Product Introduction

1.2 Global Artemisinine Market Size Forecast

1.2.1 Global Artemisinine Sales Value (2019-2030)

1.2.2 Global Artemisinine Sales Volume (2019-2030)

1.2.3 Global Artemisinine Sales Price (2019-2030)

1.3 Artemisinine Market Trends & Drivers

1.3.1 Artemisinine Industry Trends

1.3.2 Artemisinine Market Drivers & Opportunity

1.3.3 Artemisinine Market Challenges

1.3.4 Artemisinine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Artemisinine Players Revenue Ranking (2023)

2.2 Global Artemisinine Revenue by Company (2019-2024)

2.3 Global Artemisinine Players Sales Volume Ranking (2023)

2.4 Global Artemisinine Sales Volume by Company Players (2019-2024)

2.5 Global Artemisinine Average Price by Company (2019-2024)

2.6 Key Manufacturers Artemisinine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Artemisinine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Artemisinine

2.9 Artemisinine Market Competitive Analysis

2.9.1 Artemisinine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Artemisinine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Extraction from Artemisia annua

3.1.2 Semisynthetic Artemisinine

3.2 Global Artemisinine Sales Value by Type

3.2.1 Global Artemisinine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Artemisinine Sales Value, by Type (2019-2030)

3.2.3 Global Artemisinine Sales Value, by Type (%) (2019-2030)

3.3 Global Artemisinine Sales Volume by Type

3.3.1 Global Artemisinine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Artemisinine Sales Volume, by Type (2019-2030)

3.3.3 Global Artemisinine Sales Volume, by Type (%) (2019-2030)

3.4 Global Artemisinine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Injections

4.1.2 Tablets

4.1.3 Others

4.2 Global Artemisinine Sales Value by Application

4.2.1 Global Artemisinine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Artemisinine Sales Value, by Application (2019-2030)

4.2.3 Global Artemisinine Sales Value, by Application (%) (2019-2030)

4.3 Global Artemisinine Sales Volume by Application

4.3.1 Global Artemisinine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Artemisinine Sales Volume, by Application (2019-2030)

4.3.3 Global Artemisinine Sales Volume, by Application (%) (2019-2030)

4.4 Global Artemisinine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Artemisinine Sales Value by Region

5.1.1 Global Artemisinine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Artemisinine Sales Value by Region (2019-2024)

5.1.3 Global Artemisinine Sales Value by Region (2025-2030)

5.1.4 Global Artemisinine Sales Value by Region (%), (2019-2030)

5.2 Global Artemisinine Sales Volume by Region

5.2.1 Global Artemisinine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Artemisinine Sales Volume by Region (2019-2024)

5.2.3 Global Artemisinine Sales Volume by Region (2025-2030)

5.2.4 Global Artemisinine Sales Volume by Region (%), (2019-2030)

5.3 Global Artemisinine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Artemisinine Sales Value, 2019-2030

5.4.2 North America Artemisinine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Artemisinine Sales Value, 2019-2030

5.5.2 Europe Artemisinine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Artemisinine Sales Value, 2019-2030

5.6.2 Asia Pacific Artemisinine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Artemisinine Sales Value, 2019-2030

5.7.2 South America Artemisinine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Artemisinine Sales Value, 2019-2030

5.8.2 Middle East & Africa Artemisinine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Artemisinine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Artemisinine Sales Value

6.2.1 Key Countries/Regions Artemisinine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Artemisinine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Artemisinine Sales Value, 2019-2030

6.3.2 United States Artemisinine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Artemisinine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Artemisinine Sales Value, 2019-2030

6.4.2 Europe Artemisinine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Artemisinine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Artemisinine Sales Value, 2019-2030

6.5.2 China Artemisinine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Artemisinine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Artemisinine Sales Value, 2019-2030

6.6.2 Japan Artemisinine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Artemisinine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Artemisinine Sales Value, 2019-2030

6.7.2 South Korea Artemisinine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Artemisinine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Artemisinine Sales Value, 2019-2030

6.8.2 Southeast Asia Artemisinine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Artemisinine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Artemisinine Sales Value, 2019-2030

6.9.2 India Artemisinine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Artemisinine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Guilin Pharmaceutical

7.1.1 Guilin Pharmaceutical Company Information

7.1.2 Guilin Pharmaceutical Introduction and Business Overview

7.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Guilin Pharmaceutical Artemisinine Product Offerings

7.1.5 Guilin Pharmaceutical Recent Development

7.2 CAT KHANH

7.2.1 CAT KHANH Company Information

7.2.2 CAT KHANH Introduction and Business Overview

7.2.3 CAT KHANH Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CAT KHANH Artemisinine Product Offerings

7.2.5 CAT KHANH Recent Development

7.3 Novanat Bioresource

7.3.1 Novanat Bioresource Company Information

7.3.2 Novanat Bioresource Introduction and Business Overview

7.3.3 Novanat Bioresource Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Novanat Bioresource Artemisinine Product Offerings

7.3.5 Novanat Bioresource Recent Development

7.4 BEEPZ

7.4.1 BEEPZ Company Information

7.4.2 BEEPZ Introduction and Business Overview

7.4.3 BEEPZ Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 BEEPZ Artemisinine Product Offerings

7.4.5 BEEPZ Recent Development

7.5 KPC Pharmaceuticals

7.5.1 KPC Pharmaceuticals Company Information

7.5.2 KPC Pharmaceuticals Introduction and Business Overview

7.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 KPC Pharmaceuticals Artemisinine Product Offerings

7.5.5 KPC Pharmaceuticals Recent Development

7.6 BIONEXX

7.6.1 BIONEXX Company Information

7.6.2 BIONEXX Introduction and Business Overview

7.6.3 BIONEXX Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 BIONEXX Artemisinine Product Offerings

7.6.5 BIONEXX Recent Development

7.7 Guangxi xiancaotang

7.7.1 Guangxi xiancaotang Company Information

7.7.2 Guangxi xiancaotang Introduction and Business Overview

7.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Guangxi xiancaotang Artemisinine Product Offerings

7.7.5 Guangxi xiancaotang Recent Development

7.8 Sanofi

7.8.1 Sanofi Company Information

7.8.2 Sanofi Introduction and Business Overview

7.8.3 Sanofi Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Sanofi Artemisinine Product Offerings

7.8.5 Sanofi Recent Development

7.9 Natural Bio-engineering

7.9.1 Natural Bio-engineering Company Information

7.9.2 Natural Bio-engineering Introduction and Business Overview

7.9.3 Natural Bio-engineering Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Natural Bio-engineering Artemisinine Product Offerings

7.9.5 Natural Bio-engineering Recent Development

7.10 Kerui nanhai

7.10.1 Kerui nanhai Company Information

7.10.2 Kerui nanhai Introduction and Business Overview

7.10.3 Kerui nanhai Artemisinine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Kerui nanhai Artemisinine Product Offerings

7.10.5 Kerui nanhai Recent Development

8 Industry Chain Analysis

8.1 Artemisinine Industrial Chain

8.2 Artemisinine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Artemisinine Sales Model

8.5.2 Sales Channel

8.5.3 Artemisinine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Guilin Pharmaceutical

Natural Bio-engineering

Kerui nanhai

List of Tables

Table 1. Artemisinine Market Trends

Table 2. Artemisinine Market Drivers & Opportunity

Table 3. Artemisinine Market Challenges

Table 4. Artemisinine Market Restraints

Table 5. Global Artemisinine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Artemisinine Revenue Market Share by Company (2019-2024)

Table 7. Global Artemisinine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Artemisinine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Artemisinine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Artemisinine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Artemisinine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Artemisinine

Table 13. Global Artemisinine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Artemisinine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Artemisinine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Artemisinine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Artemisinine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Artemisinine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Artemisinine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Artemisinine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Artemisinine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Artemisinine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Artemisinine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Artemisinine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Artemisinine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Artemisinine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Artemisinine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Artemisinine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Artemisinine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Artemisinine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Artemisinine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Artemisinine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Artemisinine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Artemisinine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Artemisinine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Artemisinine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Artemisinine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Artemisinine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Artemisinine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Artemisinine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Artemisinine Sales Value by Region (2019-2024) & (%)

Table 44. Global Artemisinine Sales Value by Region (2025-2030) & (%)

Table 45. Global Artemisinine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Artemisinine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Artemisinine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Artemisinine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Artemisinine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Artemisinine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Artemisinine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Artemisinine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Artemisinine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Artemisinine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Artemisinine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Artemisinine Sales Volume, (2025-2030) & (K Units)

Table 57. Guilin Pharmaceutical Company Information

Table 58. Guilin Pharmaceutical Introduction and Business Overview

Table 59. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Guilin Pharmaceutical Artemisinine Product Offerings

Table 61. Guilin Pharmaceutical Recent Development

Table 62. CAT KHANH Company Information

Table 63. CAT KHANH Introduction and Business Overview

Table 64. CAT KHANH Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. CAT KHANH Artemisinine Product Offerings

Table 66. CAT KHANH Recent Development

Table 67. Novanat Bioresource Company Information

Table 68. Novanat Bioresource Introduction and Business Overview

Table 69. Novanat Bioresource Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Novanat Bioresource Artemisinine Product Offerings

Table 71. Novanat Bioresource Recent Development

Table 72. BEEPZ Company Information

Table 73. BEEPZ Introduction and Business Overview

Table 74. BEEPZ Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. BEEPZ Artemisinine Product Offerings

Table 76. BEEPZ Recent Development

Table 77. KPC Pharmaceuticals Company Information

Table 78. KPC Pharmaceuticals Introduction and Business Overview

Table 79. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. KPC Pharmaceuticals Artemisinine Product Offerings

Table 81. KPC Pharmaceuticals Recent Development

Table 82. BIONEXX Company Information

Table 83. BIONEXX Introduction and Business Overview

Table 84. BIONEXX Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. BIONEXX Artemisinine Product Offerings

Table 86. BIONEXX Recent Development

Table 87. Guangxi xiancaotang Company Information

Table 88. Guangxi xiancaotang Introduction and Business Overview

Table 89. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Guangxi xiancaotang Artemisinine Product Offerings

Table 91. Guangxi xiancaotang Recent Development

Table 92. Sanofi Company Information

Table 93. Sanofi Introduction and Business Overview

Table 94. Sanofi Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Sanofi Artemisinine Product Offerings

Table 96. Sanofi Recent Development

Table 97. Natural Bio-engineering Company Information

Table 98. Natural Bio-engineering Introduction and Business Overview

Table 99. Natural Bio-engineering Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Natural Bio-engineering Artemisinine Product Offerings

Table 101. Natural Bio-engineering Recent Development

Table 102. Kerui nanhai Company Information

Table 103. Kerui nanhai Introduction and Business Overview

Table 104. Kerui nanhai Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Kerui nanhai Artemisinine Product Offerings

Table 106. Kerui nanhai Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Artemisinine Downstream Customers

Table 110. Artemisinine Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Artemisinine Product Picture

Figure 2. Global Artemisinine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Artemisinine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Artemisinine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Artemisinine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Artemisinine Report Years Considered

Figure 7. Global Artemisinine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Artemisinine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Artemisinine Revenue in 2023

Figure 10. Artemisinine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Extraction from Artemisia annua Picture

Figure 12. Semisynthetic Artemisinine Picture

Figure 13. Global Artemisinine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Artemisinine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Artemisinine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Artemisinine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Artemisinine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Injections

Figure 19. Product Picture of Tablets

Figure 20. Product Picture of Others

Figure 21. Global Artemisinine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Artemisinine Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Artemisinine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Artemisinine Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Artemisinine Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Artemisinine Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Artemisinine Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Artemisinine Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Artemisinine Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Artemisinine Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Artemisinine Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Artemisinine Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Artemisinine Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Artemisinine Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Artemisinine Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Artemisinine Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Artemisinine Sales Volume (%), (2019-2030)

Figure 38. United States Artemisinine Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Artemisinine Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Artemisinine Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Artemisinine Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Artemisinine Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Artemisinine Sales Value by Application (%), 2023 VS 2030

Figure 44. China Artemisinine Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Artemisinine Sales Value by Type (%), 2023 VS 2030

Figure 46. China Artemisinine Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Artemisinine Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Artemisinine Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Artemisinine Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Artemisinine Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Artemisinine Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Artemisinine Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Artemisinine Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Artemisinine Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Artemisinine Sales Value by Application (%), 2023 VS 2030

Figure 56. India Artemisinine Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Artemisinine Sales Value by Type (%), 2023 VS 2030

Figure 58. India Artemisinine Sales Value by Application (%), 2023 VS 2030

Figure 59. Artemisinine Industrial Chain

Figure 60. Artemisinine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Brigatinib Tablet Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-13E9982

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Durezol Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-22W864

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Rats Model Services Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-39V834

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Argininemia Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11E9950

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions